Cross-Sector entity
All 1 tracked stories fall under one category: pharma. Of the tracked stories, 1 of 1 also mention Cerus Corporation, the most common co-covered peer. The tracked stories average 11 original sources each. Elizabeth A. Barrett appears in 1 tracked Cross-Sector story from March 3, 2026.
1 verified story tracked
Last mentioned: Mar 3, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: pharma. Of the tracked stories, 1 of 1 also mention Cerus Corporation, the most common co-covered peer. The tracked stories average 11 original sources each. Elizabeth A. Barrett appears in 1 tracked Cross-Sector story from March 3, 2026.
Computed from the 1 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Elizabeth A. Barrett. Shared-story counts are live from our verified record — not editorial picks.
UroGen Pharma and Senseonics reported strong Q4 2025 results, driven by the successful commercial launches of Zasturi and Eversense 365. Both companies are navigating critical transitions—UroGen through new reimbursement codes and Senseonics by assuming full commercial control—positioning them for significant revenue scaling in 2026.
